Invention Grant
- Patent Title: Ligand-directed covalent modification of protein
-
Application No.: US15423115Application Date: 2017-02-02
-
Publication No.: US11542492B2Publication Date: 2023-01-03
- Inventor: Russell C. Petter , Charles F. Jewell , Kwangho Lee , Aravind Prasad Medikonda , Deqiang Niu , Lixin Qiao , Juswinder Singh , Zhendong Zhu
- Applicant: Celgene CAR LLC
- Applicant Address: BM Pembroke
- Assignee: Celgene CAR LLC
- Current Assignee: Celgene CAR LLC
- Current Assignee Address: BM Pembroke
- Agency: Jones Day
- Main IPC: C12N9/96
- IPC: C12N9/96 ; G16B15/00 ; C07D405/14 ; C07D491/08 ; C07D487/04 ; C07D495/04 ; G01N33/68 ; C07D519/00 ; C07D401/04 ; C07D403/12 ; C07D405/12 ; C07D417/14 ; C07D207/16 ; C07D417/06 ; C07D493/04 ; C07D409/12 ; C07D401/14 ; C07D239/49 ; C07D513/04 ; G16C20/50 ; G16B15/30 ; C07D403/14 ; C12N9/12 ; C12N9/50 ; C12N9/00 ; C12Q1/25 ; C12Q1/37 ; C12Q1/48
Abstract:
The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
Public/Granted literature
- US20170218353A1 Ligand-Directed Covalent Modification of Protein Public/Granted day:2017-08-03
Information query
